Bruker Corporation
57.59USD
+0.2800 (+0.49%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on BRKR.
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $0.42▼ | $0.55 | 1 | 1 |
| Next quarter | $0.9▲ | $0.87 | 1 | 1 |
| Current year | $2.12▲ | $2.12 | 0 | 2 |
| Next year | $2.4▼ | $2.43 | 3 | 0 |
Beat in 3 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $0.38 | $0.49 | +0.11 (+27.5%) |
| 2026-03-31 | $0.23 | $0.31 | +0.08 (+34.8%) |
| 2025-12-31 | $0.65 | $0.59 | -0.06 (-9.8%) |
| 2025-09-30 | $0.32 | $0.45 | +0.13 (+38.8%) |
194 ratings from 30 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| JP Morgan | Downgraded from Overweight | Neutral | $60 | Oct 14, 2026 |
| TD Cowen | Maintained | Hold | $60 $62 | Oct 13, 2026 |
| Barclays | Maintained | Overweight | $58 $70 | Oct 7, 2026 |
| Guggenheim | Maintained | Buy | $70 $72 | Oct 1, 2026 |
| Leerink Partners | Maintained | Outperform | $60 $80 | Sep 29, 2026 |
| UBS | Maintained | Neutral | $45 $65 | Sep 9, 2026 |
| Citigroup | Maintained | Neutral | $60 $53 | Aug 5, 2026 |
| Citigroup | Maintained | Neutral | $44 $60 | Jul 8, 2026 |
| Leerink Partners | Maintained | Outperform | $60 $70 | Jul 7, 2026 |
| Guggenheim | Maintained | Buy | $50 $70 | Jun 29, 2026 |
| Barclays | Maintained | Overweight | $53 $60 | Jun 24, 2026 |
| JP Morgan | Maintained | Overweight | $55 $65 | Jun 8, 2026 |
| UBS | Maintained | Neutral | $40 $45 | May 7, 2026 |
| Citigroup | Maintained | Neutral | $40 $44 | May 7, 2026 |
| TD Cowen | Maintained | Hold | $43 $45 | May 7, 2026 |
| Barclays | Maintained | Overweight | $45 $53 | May 7, 2026 |
| Barclays | Maintained | Overweight | $50 $45 | Apr 15, 2026 |
| Barclays | Maintained | Overweight | $50 $45 | Apr 14, 2026 |
| Guggenheim | Maintained | Buy | $58 $50 | Mar 30, 2026 |
| Citigroup | Maintained | Neutral | $53 $40 | Feb 13, 2026 |
| Goldman Sachs | Maintained | Sell | $40 $35 | Feb 13, 2026 |
| TD Cowen | Maintained | Hold | $53 $43 | Feb 13, 2026 |
| Barclays | Maintained | Overweight | $55 $50 | Feb 13, 2026 |
| Guggenheim | Maintained | Buy | $53 $58 | Jan 26, 2026 |
| Citigroup | Maintained | Neutral | $40 $53 | Jan 16, 2026 |
70 filings from 19 insiders · 13 buy / 6 sell over 6m
Officers and directors of BRKR, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Munch MarkOfficer, EXEC VP&PRES BRUKER NANO INC. | ExerciseStock Option (Right to Purchase) | 2.0k | — | — | Sep 15, 2026 |
| Munch MarkOfficer, EXEC VP&PRES BRUKER NANO INC. | Sell | 2.0k | $52.87 | $106k | Sep 15, 2026 |
| Munch MarkOfficer, EXEC VP&PRES BRUKER NANO INC. | Exercise | 2.0k | $22.19 | $44k | Sep 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Aug 14, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $57.60 | $115k | Aug 14, 2026 |
| BURES THOMASOfficer | Grant | 4.0k | — | — | Aug 14, 2026 |
| MUNCH MARK ROBERTOfficer | Grant | 14.4k | — | — | Aug 14, 2026 |
| PRAUSE BURKHARDOfficer | Grant | 3.3k | — | — | Aug 14, 2026 |
| SREGA JUERGENOfficer | Grant | 16.9k | — | — | Aug 14, 2026 |
| LAUKIEN FRANK HChief Executive Officer | Grant | 29.5k | — | — | Aug 14, 2026 |
| HERMAN GERALD NChief Financial Officer | Grant | 15.8k | — | — | Aug 14, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Jul 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $60.25 | $121k | Jul 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Jun 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $54.76 | $110k | Jun 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | May 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $43.90 | $88k | May 15, 2026 |
| BERNARD THIERRYDirector | Grant | 2.9k | — | — | May 15, 2026 |
| MUNCH MARK ROBERTOfficer | Exercise | 2.0k | $22.19 | $44k | Apr 15, 2026 |
| MUNCH MARK ROBERTOfficer | Sell | 2.0k | $39.90 | $80k | Apr 15, 2026 |
No analyst notes on BRKR yet.
Analyst Ratings
12 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 1 | 5 | 6 | 1 | 0 | Hold2.54 |
| 1 mo ago | 2 | 5 | 5 | 1 | 0 | Buy2.38 |
| 2 mo ago | 2 | 6 | 4 | 1 | 0 | Buy2.31 |
| 3 mo ago | 2 | 6 | 4 | 1 | 0 | Buy2.31 |
Members whose judged calls on BRKR have played out most reliably.
No settled calls on BRKR yet. Nobody has filed a call with a deadline on it.
A member is listed once they have three judged calls on a name.
A call with a target is judged on whether the price reaches it by the deadline, counting each day's high (a buy) or low (a sell) from the day after the call was made. A call without one is judged on whether the price at the close on the deadline is higher (a buy) or lower (a sell) than the price the call was made at: the live price when it was saved, for a call made with Make a call, or the last close before the day it was filed, for a call made in a note. Not against the market or an index.
A percentage appears once five calls have reached their deadline. A target reached sooner is shown as played out early, and counts toward the percentage when its deadline passes, because a miss cannot be known before then.
A member’s prediction, judged on price history · not investment advice